BICO Group AB (publ)

OTC-CLLKF
OTCMKTS NYSE
Healthcare Medical Devices
Global Rank
#18002
Country Rank
n/a
Market Cap
272.38 M
Price
3.83
Change (%)
0.77%
Volume
780

BICO Group AB (publ)'s latest marketcap:

272.38 M

As of 06/07/2025, BICO Group AB (publ)'s market capitalization has reached $272.38 M. According to our data, BICO Group AB (publ) is the 18002th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 272.38 M
Revenue (ttm) 185.77 M
Net Income (ttm) -21,050,408
Shares Out 0
EPS (ttm) -0.3
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/19/2025
Market Cap Chart
Data Updated: 06/07/2025

BICO Group AB (publ)'s yearly market capitalization.

BICO Group AB (publ) has seen its market value drop from $1.48 B to $272.38 M since 2020, representing a total decrease of 81.55% and an annual compound decline rate (CAGR) of 31.68%.
Date Market Cap Change (%)
06/07/2025 $272.38 M 32.15%
12/30/2024 $204.6 M -48.67%
12/29/2023 $398.59 M -44.29%
12/30/2022 $715.5 M -62.5%
12/30/2021 $1.91 B 29.22%
12/30/2020 $1.48 B

Company Profile

BICO Group AB (publ) Overview

BICO Group AB (publ) is a global provider of hardware, laboratory automation, and software solutions, serving customers in North America, Europe, Asia, and internationally.

Business Segments

  • Bioprinting: Offers 3D bioprinters, bioinks, and services to accelerate drug discovery and development.
  • Life Science Solutions: Supplies lab instrumentation, consumables, and applications for cell culture, imaging, sorting, and sample preparation.
  • Lab Automation: Provides proprietary software, automation technology integration, and consulting services for automated laboratory systems.

Products & Services

  • 3D bioprinters and bioinks for various applications.
  • Lab instruments and solutions for diagnostics manufacturing.
  • Green Button Go Suite software for connected workflows.
  • Reagents, bioinks, plates, and tissue models.

Industries Served

The company caters to:

  • Pharma & Biopharma
  • Biotech
  • Diagnostics
  • Academia & Research
  • Cosmetics

Distribution & History

BICO Group AB (publ) distributes its products through sales organizations and a distributor network. Formerly known as Cellink AB (publ), the company rebranded in August 2021. Founded in 2016, it is headquartered in Gothenburg, Sweden.

Frequently Asked Questions

  • What is BICO Group AB (publ)'s (OTC-CLLKF) current market cap?
    As of 06/07/2025, BICO Group AB (publ) (including the parent company, if applicable) has an estimated market capitalization of $272.38 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • BICO Group AB (publ) global market capitalization ranking is approximately 18002 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.